Pharmaceutical Microbiology

New Developments with Sterile Disposable Technology and Single-Use Systems for Aseptic Processing. In the past three to five years, there have been a number of advances in single-use sterile, disposable technologies, which have helped to both reduce the risk of contamination and to streamline process operations. The majority of these technological developments are oriented towards the manufacturing of sterile products, particularly aseptically filled products. In relation to this, Tim Sandle has written a review paper: http://www.pharmamicroresources.com/…/n ew-developments-with…

Biocontamination control - Moves toward a better standard. Significant progress has been made in revising the international cleanroom standard ISO 14698. The focus of the standard is essentially environmental monitoring, along with biocontamination: https://www.researchgate.net/…/28473100 5_Biocontamination_c…

Bacteria in the nose influence cold severity. Colds vary in their severity and for how long they last for. The reason is not solely down to the type of virus or the relative health of individuals. The bacterial population of the nose is also a factor, according to new research: https://www.pharmamicroresources.com/…/ bacteria-in-nose-inf…

Clonal characterization of Staphylococcus aureus. Many typing methods have been developed to perform subspecies differentiation needed in epidemiological studies. In this context, the aim of the present study was to compare sequence-based typing methods, such as Multilocus sequence typing (MLST) and spa typing, in order to assess their discriminatory power and concordance: https://www.pharmamicroresources.com/…/ clonal-characterizat…

The CDC Handbook: A Guide to Cleaning and Disinfecting Cleanrooms. The book provides comprehensive detail on different types of disinfectants and their modes of action; explains the problems of microbial destruction and resistance; introduces cleaning techniques and the latest safety regulations; expounds upon the application of cleaning within healthcare and pharmaceutical environments, noting current national and international standards. The book also provides guidance on disinfectant efficacy testing. See: https://www.amazon.com/CDC-Handbook-Clean ing-Disinfectin…/…/

Fungi are key players of the deep biosphere https://www.pharmamicroresources.com/…/ fungi-are-key-player… #fungi

To make this task easier, German pharmaceutical firm Bayer is experimenting with artificial intelligence. According to the website PharmaPhorum, Bayer has linked up with professional services firm Genpact for the development and has embarked upon a multi-year agreement for Pharmacovigilance Artificial Intelligence products: http://www.digitaljournal.com/…/bayer-a pplie…/article/536194

EMA launches new corporate website. The website has a number of new features to improve user experience, including... http://www.pharmamicroresources.com/…/e ma-launches-new-corp…

Superbugs to 'kill millions' by 2050 https://www.pharmamicroresources.com/…/ superbugs-to-kill-mi…

Malaria and Malnutrition Causing Unprecedented Mortality Rates in Children. An average of ten children per day died last month in the hospital in Magaria in southern Niger, an alarming mortality rate mostly due to malnutrition and malaria in children under five, said the international medical humanitarian organization Doctors Without Borders/Medecins Sans Frontieres (MSF) on Tuesday. MSF, in collaboration with Niger’s Ministry of Health (MOH), is currently treating 730 children who are admitted to the hospital, including 208 who are critically ill and crowded into the pediatric intensive care unit: http://www.pharmamicroresources.com/…/m alaria-and-malnutrit…

Free to read article - Novel Methods to Address Antimicrobial Resistance: Humans face the very real risk of a future without antibiotics. The implications of this are that life expectancy could fall due to people dying from diseases that are readily treatable today. One concern for the future is the re- emergence of diseases that are ‘officially’ extinct, such as tuberculosis (a disease caused by Mycobacterium tuberculosis). The other concern is that without effective antibiotics, human society will no longer be able to conduct the types of medical procedures that can lead to immunosuppression. Such therapies include those for cancer treatments or to address autoimmune disorders, see: https://www.researchgate.net/…/26033866 5_Novel_Methods_to_A…

FDA’s new policy to better inform consumers about retailers selling recalled foods. Stop Foodborne Illness, the national advocacy organization that represents individuals and families in the fight against foodborne illness, issued a statement today applauding a new FDA policy announced by FDA Commissioner Scott Gottlieb, M.D.: http://www.pharmamicroresources.com/…/f das-new-policy-to-be…

Researchers have begun undertaking examination into the effectiveness of treatments for skin diseases. The focus is with skin infections that are resistant to common antibiotics, especially diseases that are multi-drug resistant: http://www.digitaljournal.com/…/key-stu dy-se…/article/536007

Human microbiome - While application has primarily been clinical, there are implications for pharmaceuticals and healthcare stemming from the research: http://www.pharmamicroresources.com/…/1 1/human-microbiome.h…

GMP in Practice: Regulatory Expectations for the Pharmaceutical Industry. James Vesper and Tim Sandle have a new book – ‘GMP in Practice: Regulatory Expectations for the Pharmaceutical Industry’, Fifth Edition, Revised and Expanded: http://www.pharmamicroresources.com/…/g mp-in-practice-regul…

Antibiotic resistance is causing significant medical problems and while a key factor is over-prescription of antibiotic medications, there are other factors. Once factor, according to new research, could be common agricultural herbicides: http://www.digitaljournal.com/…/farm-he rbici…/article/536004

Standards and controls for skin disinfection: https://www.researchgate.net/…/29296671 4_Standards_and_cont…

E. coli's adaptation helps explain resistance to certain drugs. Long before bacteria had to contend with antibiotic drugs, they had to survive extreme temperatures as Earth warmed and cooled over millennia. Could the adaptations they evolved to temperature -- especially heat -- help explain why certain strains are resistant to certain drugs? A new study by a research team at the University of California-Los Angeles that includes Santa Fe Institute External Professor Pamela Yeh suggests that defenses against extreme temperatures, do, indeed, give E. coli bacteria an advantage in fending off certain drugs: http://www.pharmamicroresources.com/…/e -colis-adaptation-he…

Are artificial sweeteners harmful? This a question that scientists have been grappling with for several decades. While sweeteners help with weight-loss programs, new evidence suggests they affect our microbiome: http://www.digitaljournal.com/…/artific ial-s…/article/535998

des sujets très intéressants et d'actualités

Its helpful page

I study in microbiology,pharmaceutical microbiology is one of most important branch.this page give me lot of knowledge. .

Thank you..

Great site!

Great page

Good publication

Good book great help my jobs. I write many sops. Thanks lot.

Nice my boos

des sujets très intéressants et d'actualités

Its helpful page

I study in microbiology,pharmaceutical microbiology is one of most important branch.this page give me lot of knowledge. .

Thank you..

Great site!

Great page

Good publication

Good book great help my jobs. I write many sops. Thanks lot.

Nice my boos